Earnings Feed
Start Free
Mineralys Therapeutics, Inc.·4

Feb 20, 7:47 PM ET

SBLENDORIO GLENN 4

4 · Mineralys Therapeutics, Inc. · Filed Feb 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Mineralys (MLYS) Director Glenn Sblendorio Receives Equity Awards

What Happened

  • Glenn Sblendorio, a director of Mineralys Therapeutics (MLYS), received two equity awards on 2026-02-19: 6,200 restricted stock units (RSUs) and 8,300 derivative awards (stock-option style). Both grants show an acquisition price of $0.00 on the Form 4 and were reported on 2026-02-20. These are grants/awards (not open-market buys or sales), so they are compensation-related rather than a market trade.

Key Details

  • Transaction date: 2026-02-19; Form 4 filed: 2026-02-20.
  • Awards: 6,200 RSUs (A) at $0.00; 8,300 derivative award (A) at $0.00.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes:
    • F1: The 6,200 RSUs were granted for no additional cash; each RSU converts to one share upon vesting in one annual installment following the grant.
    • F2: The 8,300 derivative award is a stock option that vests in 12 substantially equal monthly installments after the grant date.
  • Timeliness: Filing appears timely (period end 2026-02-19; filing 2026-02-20); no late filing flag noted.

Context

  • RSUs convert into shares only upon vesting, and the option-style award vests monthly — neither represents immediately tradable shares at grant. Such grants are common director compensation to align interests with shareholders; they are informational but not direct bullish/bearish trades.

Insider Transaction Report

Form 4
Period: 2026-02-19
Mineralys Therapeutics, Inc.MLYS
SBLENDORIO GLENN
Director
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-19+6,200→ 6,200 total
  • Award

    Stock Option

    [F2]
    2026-02-19+8,300→ 8,300 total
    Exercise: $28.06Exp: 2036-02-19→ Common Stock (8,300 underlying)
Footnotes (2)
  • [F1]Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting of these RSUs in one annual installment following the date of grant.
  • [F2]The stock option vests in 12 substantially equal monthly installments following the date of grant.
Signature
/s/ Adam Levy, Attorney-in-fact|2026-02-20

Documents

1 file
  • 4
    wk-form4_1771634854.xmlPrimary

    FORM 4